Back to today’s briefing

Story perspectives

Pharma Leaders Hope for Drug Pricing Reforms Ahead

1/26/2025

29 7

Summary

Story summary

Pharmaceutical companies are buzzing with optimism as they anticipate a shift in drug pricing under the Trump administration. With a focus on reforming pharmacy benefit managers and revising the Inflation Reduction Act, industry leaders are eager to collaborate. They hope for greater transparency and direct savings for patients, despite lingering uncertainties about health policies and key appointments.

1 of 1

Story summary

Pharmaceutical companies are buzzing with optimism as they anticipate a shift in drug pricing under the Trump administration. With a focus on reforming pharmacy benefit managers and revising the Inflation Reduction Act, industry leaders are eager to collaborate. They hope for greater transparency and direct savings for patients, despite lingering uncertainties about health policies and key appointments.